B
Barry R. Davis
Researcher at University of Texas at Austin
Publications - 351
Citations - 50989
Barry R. Davis is an academic researcher from University of Texas at Austin. The author has contributed to research in topics: Chlorthalidone & Amlodipine. The author has an hindex of 78, co-authored 342 publications receiving 47899 citations. Previous affiliations of Barry R. Davis include Tulane University & Cardiovascular Institute of the South.
Papers
More filters
Journal ArticleDOI
Risk stratification of sudden cardiac death in hypertension.
TL;DR: ECG predictors of sudden cardiac death and the importance of risk stratification for appropriate management of hypertension are reviewed.
Journal ArticleDOI
Association of orthostatic hypertension with mortality in the Systolic Hypertension in the Elderly Program.
William J. Kostis,Davit Sargsyan,Choukri Mekkaoui,Abel E. Moreyra,Javier Cabrera,Nora M. Cosgrove,Jeanine E. Sedjro,John B. Kostis,William C. Cushman,William C. Cushman,John S Pantazopoulos,Sara L. Pressel,Barry R. Davis +12 more
TL;DR: The increased risk of all-cause mortality associated with orthostatic hypertension was observed in both the active and placebo groups without significant interaction between randomization group and the effect on mortality.
Journal ArticleDOI
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial
Roberto Bolli,Emerson C. Perin,James T. Willerson,Phillip C. Yang,Jay H. Traverse,Timothy D. Henry,Carl J. Pepine,Raul D. Mitrani,Joshua M. Hare,Michael P. Murphy,Keith L. March,Sohail Ikram,David P. Lee,Connor O'Brien,Jean-Bernard Durand,Kathy D. Miller,Joao A.C. Lima,Mohammad R. Ostovaneh,Bharath Ambale-Venkatesh,Adrian P. Gee,Sara Richman,Doris A. Taylor,Shelly L. Sayre,Judy Bettencourt,Rachel W. Vojvodic,Michelle Cohen,Lara M. Simpson,Dejian Lai,David Aguilar,Catalin Loghin,Lem Moyé,Ray F. Ebert,Barry R. Davis,Robert D. Simari +33 more
TL;DR: In this first-in-human study of cell therapy in patients with AIC, transendocardial administration of allo-MSCs appears safe and feasible, and CMR was successfully performed in the majority of the HF patients with devices.
Use of Repeated Blood Pressure and Cholesterol Measurements to Improve Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis
Ellie Paige,Jessica K. Barrett,Lisa Pennells,Michael J. Sweeting,Peter Willeit,Peter Willeit,Emanuele Di Angelantonio,Vilmundur Gudnason,Børge G. Nordestgaard,Bruce M. Psaty,Bruce M. Psaty,Uri Goldbourt,Lyle G. Best,Gerd Assmann,Jukka T. Salonen,Paul J. Nietert,W. M. Monique Verschuren,Eric J. Brunner,Richard A. Kronmal,Veikko Salomaa,Stephan J. L. Bakker,Gilles R. Dagenais,Shinichi Sato,Jan-Håkan Jansson,Johann Willeit,Altan Onat,Agustín Gómez de la Cámara,Ronan Roussel,Henry Völzke,Rachel Dankner,Robert W. Tipping,Tom W. Meade,Chiara Donfrancesco,Lewis H. Kuller,Annette Peters,John Gallacher,Daan Kromhout,Hiroyasu Iso,Matthew Knuiman,Edoardo Casiglia,Maryam Kavousi,Luigi Palmieri,Johan Sundström,Barry R. Davis,Inger Njølstad,David Couper,John Danesh,Simon G. Thompson,Angela M. Wood +48 more
TL;DR: In this paper, the added value of incorporating information from repeated blood pressure and cholesterol measurements to predict cardiovascular disease (CVD) risk has not been rigorously assessed, and the authors used data on...
Journal ArticleDOI
Treatment resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Paul Muntner,Barry R. Davis,William C. Cushman,Sripal Bangalore,David A. Calhoun,Sara L. Pressel,Henry R. Black,John B. Kostis,Jeff Probstfield,Paul K. Whelton,Mahboob Rahman +10 more
TL;DR: In this paper, the authors defined aTRH as blood pressure not at goal (systolic/diastolic blood pressure ≥140/90 mm Hg) while taking ≥3 classes of antihypertensive medication or taking ≥4 classes of medication with blood pressure at goal during the year 2 ALLHAT study visit (1996-2000).